Video Hero Poster

Beyond fulfilment

Contact Us

Abcur AB is the Nordic division of ADVANZ PHARMA. We focus on the development, registration and marketing of a wide range of niche prescriptions within the Nordic markets’ vital therapeutic indications, including intensive care, pain management, ophthalmology, endocrinology and anaesthesia.

Our products are manufactured according to Good Manufacturing Practice (GMP) and European law by certified manufacturers, as well as in accordance with European environmental requirements to ensure the delivery of high-quality products.

We are continuously seeking to expand our product portfolio within existing therapeutic areas and where we see possibilities in new areas.

Image for ADVANZ PHARMA Corp. Announces First Quarter 2019 Results

Press Releases — 16 May 2019

ADVANZ PHARMA Corp. Announces First Quarter 2019 Results

Learn more

Press Releases — 14 May 2019

ADVANZ PHARMA Corp. Announces Release Date for First Quarter 2019 Results

Learn more

Press Releases — 12 Sep 2018

Further update provided on recently completed recapitalization transaction and the issue price of its private placement

Learn more
Image for Concordia International corp. announces special meeting of shareholders to approve name change

Press Releases — 05 Oct 2018

Special meeting of shareholders announced to approve name change

Learn more
Image for Concordia international corp. announces intention to rebrand as ADVANZ PHARMA following its successful recapitalization

Press Releases — 09 Oct 2018

Concordia International Corp. announces intention to rebrand as ADVANZ PHARMA following its successful recapitalization

Learn more

Press Releases — 15 Oct 2018

Pharmaceutical industry expert added to board of directors

Learn more